NCT06089408 Weighted Blanket Use to Reduce Anxiety in Oncology Patients
| NCT ID | NCT06089408 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Condition | Hematopoietic and Lymphoid Cell Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 114 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 114 participants in total. It began in 2023-08-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial compares the effect of using weighted blankets versus regular blankets during first time infusions (e.g. chemotherapy, targeted therapy etc.) to decrease adverse side effects such as anxiety and distress in cancer (oncology) patients. Feeling safe, comforted, and grounded in the world are some of the benefits noted by individuals who use weighted blankets. Deep touch pressure (DTP) has been found to reduce symptoms of stress and anxiety and is defined as a sensation one feels when being hugged, squeezed, or held. DTP affects the nervous system by creating a calming effect which may lower stress and increase feelings of well-being. The use of weighted blankets may help to manage anxiety and distress during chemotherapy or immunotherapy infusions.
Eligibility Criteria
Inclusion Criteria: * Age 18 years of age and older * About to begin either targeted or cytotoxic chemotherapy * Able to comprehend and sign a consent form * Able to read and complete surveys * Alert and oriented Exclusion Criteria: * Currently using a weighted blanket at home * Non-English speaking * Peripheral neuropathy * Fibromyalgia * Open pressure ulcer * Recent surgical flap * Claustrophobic * Weight 45 kg or less
Contact & Investigator
Allison De Villiers, MSN, RN, ONC
PRINCIPAL INVESTIGATOR
Ohio State University Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT06089408 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematopoietic and Lymphoid Cell Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06089408 currently recruiting?
Yes, NCT06089408 is actively recruiting participants. Contact the research team at OSUCCCClinicaltrials@osumc.edu for enrollment information.
Where is the NCT06089408 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT06089408 clinical trial?
NCT06089408 is sponsored by Ohio State University Comprehensive Cancer Center. The principal investigator is Allison De Villiers, MSN, RN, ONC at Ohio State University Comprehensive Cancer Center. The trial plans to enroll 114 participants.